Company Data
Prelude Therapeutics Incorporated
Ticker
PRLD
Current Price
$1.81 -15.81%
Market Cap
$113.8M
Price Target
Refer to Report
Volume
1.4M
52wk Range
$0.6101 - $4.22
Overview
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.